Evidence map›Paper›PMID 42918991›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2027

Integration of Multiomics Datasets to Identify Allergy Biomarkers and Protective Signatures.

Isidro Sobrino, José de la Fuente

Abstract read
PubMed Publisher
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2027. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Isidro SobrinoSaBio, Instituto de Investigación en Recursos Cinegéticos, IREC (CSIC, UCLM, JCCM), Ciudad Real, Spain.
José de la FuenteSaBio, Instituto de Investigación en Recursos Cinegéticos, IREC (CSIC, UCLM, JCCM), Ciudad Real, Spain. isidro.sobrino@uclm.es.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The identification of biomarkers for diseases such as allergies requires analytical strategies capable of handling high-dimensional and heterogeneous biological data. Advances in omics technologies have enabled the systematic exploration of molecular features across multiple biological levels. However, their effective integration and interpretation remain challenging. In this chapter, we present a data-driven bioinformatic framework for biomarker discovery based on single-omics and multi-omics datasets, with a particular focus on allergy-related applications. We describe complementary strategies for biomarker prioritization, including differential analysis, ranking-based approaches, machine learning-driven feature selection, network-based methods, and supervised multi-omics integration using DIABLO. Special attention is given to experimental design, batch correction, data leakage prevention, and validation principles. The proposed workflow adapts methodological approaches to the structure and availability of the data, supporting horizontal, vertical, and exploratory diagonal integration scenarios. This chapter provides practical guidance and reproducible examples to assist researchers in extracting biologically meaningful and robust biomarkers from omics and multi-omics studies.

Indexed as

BiomarkersComputational BiologyHypersensitivityMultiomicsGenomicsHumansMachine LearningBiomarkersAllergyBiodataBiomarkerMachine learningNetworkOmics

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.